The drugmaker at the center of a firestorm over hefty price increases on the lifesaving EpiPen put a special incentive plan in place more than two years ago that rewards executives only if they hit aggressive profit targets.
from WSJ.com: US Business http://ift.tt/2bSV22Q
via IFTTT
No comments:
Post a Comment